NCT02403596View on ClinicalTrials.gov

Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban

PHASE3CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

October 20, 2015

Primary Completion Date

August 29, 2017

Study Completion Date

August 29, 2017

Conditions
Blood Loss After a Total Hip Replacement
Interventions
DRUG

Exacyl®

OTHER

Placebo of Exacyl®

Trial Locations (4)

29200

HIA Clermont Tonnerre Brest, Brest

29287

Polyclinique de Keraudren, Brest

29609

CHRU Brest, Brest

29672

CH Morlaix, Morlaix

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

University Hospital, Brest

OTHER